Considering 30-days investment horizon, and your above average risk tolerance our recommendation regarding MetLife is 'Strong Hold'. Macroaxis provides MetLife buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding MetLife positions. The advice algorithm takes into account all of MetLife available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from MetLife buy-and-hold prospective. Please see also MetLife Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for muliple equity instruments please use Instant Ratings tool.
For the selected time horizon MetLife has a risk adjusted performance of 0.01, jensen alpha of 0.0, total risk alpha of 0.0 and treynor ratio of 0.0Macroaxis advice tool can be used to complement MetLife buy, hold, or sell recommendation provided by experts. It analyzes the firm potential to grow against your specific risk preferences and investment horizon. To make sure MetLife is not overpriced, please verify all MetLife fundamentals including its Debt to Equity, and the relationship between EBITDA and Earnings Per Share . Given that MetLife has Price to Earning of 9.03X, we recommend you check MetLife market performance and probability of bankruptcy to make sure the company can sustain itself in the current economic cycle given your last-minute risk tolerance and investing horizon.
MetLife Trading Alerts and Improvement Suggestions
MetLife has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial commitments
About 62.0% of the company outstanding shares are owned by corporate insiders
MetLife has relatively low volatility with skewness of 0.42 and kurtosis of 1.23. However, we advise all investors to independently investigate MetLife to ensure market all accessible information is consistent with the expectations about its upside potential and future risk-adjusted return.